Why is GKB Ophthalmics falling/rising?

As of 11-Nov, GKB Ophthalmics Ltd is experiencing a decline in its stock price, currently at 62.13, reflecting a decrease of 2.5 or 3.87%. The stock has underperformed its sector by 4.02% today and has been on a downward trend for the last two days, with a total decline of 5.85%. It opened with a loss of 3.84% and reached an intraday low of Rs 61. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has fallen by 7.25%, and its year-to-date performance shows a significant decline of 37.08%. The company's weak long-term fundamentals, highlighted by a -166.65% CAGR growth in operating profits over the last five years and a negative EBIT to interest ratio of -0.20, contribute to the stock's poor performance.
In the broader market context, GKB Ophthalmics has consistently underperformed against the benchmark, with a 1-year return of -41.93% compared to the Sensex's gain of 5.50%. This underperformance has been evident over the last three years, where the stock has not only generated negative returns but has also lagged behind the BSE500 in each of the last three annual periods. The company's financial struggles, including negative EBITDA and low profitability per unit of shareholders' funds, further exacerbate investor concerns, leading to a lack of confidence in the stock's future performance.